Autres langues DMK Pharmaceuticals Corporation

Actions

DMKPQ

US00547W3079

Marché Fermé - OTC Markets Autres places de cotation 21:54:25 15/07/2024			Varia. 5j.	Varia. 1 janv.
0,026 ^USD	-13,33 %		-35,00 %	-96,29 %

01/07	Ebrahim ?Eboo ? Versi quitte son poste de directeur général de DMK Pharmaceuticals Corporation	CI
01/07	DMK Pharmaceuticals Corporation annonce des changements de direction	CI

Autres langues

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

Ebrahim ?Eboo? Versi Separates from His Role as Chief Executive Officer of DMK Pharmaceuticals Corporation	01/07
DMK Pharmaceuticals Corporation Announces Management Changes	01/07
DMK Pharmaceuticals : Management Change/Compensation Form 8 K	01/07
ZMI Pharma, Inc acquired Automated assembly systems, all patents, inventory of DMK Pharmaceuticals Corporation for $3.2 million.	20/06
First Motion for Exclusivity Period Extension Approved For DMK Pharmaceuticals Corporation	14/06
Motion for Case Conversion Filed by DMK Pharmaceuticals Corporation	11/06
First Motion for Exclusivity Period Extension Filed by DMK Pharmaceuticals Corporation	30/05
Motion for Asset Sale Approved for DMK Pharmaceuticals Corporation	08/05
North American Morning Briefing : Stock Futures Edge Lower Ahead of PPI Inflation Gauge	11/04
North American Morning Briefing : Focus Turns to -2-	04/04
Bidding Procedure Approved for DMK Pharmaceuticals Corporation	04/04
Motion for Asset Sale Filed by DMK Pharmaceuticals Corporation	21/03
DMK Pharmaceuticals Corporation(NasdaqCM:DMK) dropped from S&P TMI Index	08/02
Motion for Joint Administration Approved for DMK Pharmaceuticals Corporation	06/02
DMK Pharmaceuticals Corporation(OTCPK:DMKP.Q) dropped from NASDAQ Composite Index	06/02
DMK Pharmaceuticals Commences Restructuring Proceeding	03/02
Motion for Joint Administration Filed by DMK Pharmaceuticals Corporation	02/02
DMK Pharmaceuticals Corporation Filed for Bankruptcy	02/02
DMK Pharmaceuticals Corporation Announces Board Appointments	31/01
DMK Pharmaceuticals Regains Full Rights to Commercialize ZIMHI	21/12

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues DMK Pharmaceuticals Corporation

Actions

DMKPQ

US00547W3079

Autres langues

Filtres